Cite Filings / KURA / 0000950170-22-006540

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Kura Oncology, Inc. Filed 2022-04-28 Acc 0000950170-22-006540

Documents 1

DEFA14A Proxy Materials , kura_defa_14a_2022.htm

Around this filing

2023-04-06 DEFA14A Proxy Materials
2022-05-04 10-Q Quarterly Report
2022-05-04 8-K Results of operations
2022-04-28 DEFA14A Proxy Materials
2022-04-28 DEF 14A Proxy Statement
2021-06-04 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading kura_defa_14a_2022.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…